Researchers in the US have developed a new drug that can be delivered  directly into the eye via an eye dropper to shrink down and dissolve  cataracts - the leading cause of blindness in humans.   While the effects have yet to be tested on humans, the team from  the University of California, San Diego hopes to replicate the findings  in clinical trials and offer an alternative to the only treatment that’s  currently available to cataract patients - painful and often  prohibitively expensive surgery.   Affecting  tens of millions of people worldwide, cataracts cause the lens  of the eye to become progressively cloudy, and when left untreated, can  lead to total blindness. This occurs when the structure of the  crystalline proteins that make up the lens in our eyes deteriorates,  causing the damaged or disorganized proteins to clump and form a milky  blue or brown layer. While cataracts cannot spread from one eye to the  other, they can occur independently in   ...